0001127602-21-003721.txt : 20210203
0001127602-21-003721.hdr.sgml : 20210203
20210203164404
ACCESSION NUMBER: 0001127602-21-003721
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210201
FILED AS OF DATE: 20210203
DATE AS OF CHANGE: 20210203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Calcaterra Chris M.
CENTRAL INDEX KEY: 0001640771
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37463
FILM NUMBER: 21586765
MAIL ADDRESS:
STREET 1: C/O GLAUKOS CORPORATION
STREET 2: 26051 MERIT CIRCLE, SUITE 103
CITY: LAGUNA HILLS
STATE: CA
ZIP: 92653
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLAUKOS Corp
CENTRAL INDEX KEY: 0001192448
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 229 AVENIDA FABRICANTE
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92672
BUSINESS PHONE: 949-367-9600
MAIL ADDRESS:
STREET 1: 229 AVENIDA FABRICANTE
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92672
FORMER COMPANY:
FORMER CONFORMED NAME: GLAUKOS CORP
DATE OF NAME CHANGE: 20020925
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-02-01
0001192448
GLAUKOS Corp
GKOS
0001640771
Calcaterra Chris M.
C/O GLAUKOS CORPORATION
229 AVENIDA FABRICANTE
SAN CLEMENTE
CA
92672
1
Chief Operating Officer
Common Stock
2021-02-01
4
M
0
60417
16.49
A
224223
D
Common Stock
2021-02-01
4
S
0
13201
86.6477
D
211022
D
Common Stock
2021-02-01
4
S
0
6030
87.7853
D
204992
D
Common Stock
2021-02-01
4
S
0
24401
88.7377
D
180591
D
Common Stock
2021-02-01
4
S
0
16785
89.4434
D
163806
D
Stock Options (Right to Buy)
16.49
2021-02-01
4
M
0
60417
0
D
2026-03-10
Common Stock
60417
0
D
These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices.
Includes 5,967 restricted stock units that have not yet vested or been delivered to the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $86.22 to $87.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $87.235 to $88.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $88.23 to $89.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $89.23 to $89.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This option was granted on March 10, 2016, and has a four-year vesting schedule in which 25% vests on the first year anniversary date of the grant and the remainder vests in equal monthly installments for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date.
/s/ Diana Scherer, Attorney-in-Fact
2021-02-03